Clindamycin, an antibiotic, is prescribed to treat infections of the respiratory tract, skin, pelvis, vagina, and abdomen. Antibiotics will not work for colds, flu, or other viral infections.
An antibacterial agent that is a semisynthetic analog of lincomycin.
Indication and Usage
Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (eg, erythromycin).
Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tuboovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection.
Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections.
Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections.
Pneumococci: Serious respiratory tract infections.
Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Clindamycin HCl and other antibacterial drugs, Clindamycin HCl should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Clindamycin side effects.
Mild Diarrhea;
- Nausea;
- Upset Stomach;
- Vomitin
Skin Dryness;
- Reddened Skin;
- Peeling Skin;
- Itching;
- Burning;
DOSAGE AND ADMINISTRATION
If significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box).
Adults: Serious infections —150 to 300 mg every 6 hours.
More severe infections —300 to 450 mg every 6 hours.
Pediatric Patients: Serious infections —8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections —16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses.
To avoid the possibility of esophageal irritation, Clindamycin HCl Capsules should be taken with a full glass of water.
Serious infections due to anaerobic bacteria are usually treated with Clindamycin Phosphate Sterile Solution. However, in clinically appropriate circumstances, the physician may elect to initiate treatment or continue treatment with Clindamycin HCl Capsules.
In cases of ß-hemolytic streptococcal infections, treatment should continue for at least 10 days.
An antibacterial agent that is a semisynthetic analog of lincomycin.
Indication and Usage
Clindamycin is indicated in the treatment of serious infections caused by susceptible anaerobic bacteria. Clindamycin is also indicated in the treatment of serious infections due to susceptible strains of streptococci, pneumococci, and staphylococci. Its use should be reserved for penicillin-allergic patients or other patients for whom, in the judgment of the physician, a penicillin is inappropriate. Because of the risk of colitis, as described in the WARNING box, before selecting clindamycin the physician should consider the nature of the infection and the suitability of less toxic alternatives (eg, erythromycin).
Anaerobes: Serious respiratory tract infections such as empyema, anaerobic pneumonitis and lung abscess; serious skin and soft tissue infections; septicemia; intra-abdominal infections such as peritonitis and intra-abdominal abscess (typically resulting from anaerobic organisms resident in the normal gastrointestinal tract); infections of the female pelvis and genital tract such as endometritis, nongonococcal tuboovarian abscess, pelvic cellulitis and postsurgical vaginal cuff infection.
Streptococci: Serious respiratory tract infections; serious skin and soft tissue infections.
Staphylococci: Serious respiratory tract infections; serious skin and soft tissue infections.
Pneumococci: Serious respiratory tract infections.
Bacteriologic studies should be performed to determine the causative organisms and their susceptibility to clindamycin.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of Clindamycin HCl and other antibacterial drugs, Clindamycin HCl should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
Clindamycin side effects.
Mild Diarrhea;
- Nausea;
- Upset Stomach;
- Vomitin
Skin Dryness;
- Reddened Skin;
- Peeling Skin;
- Itching;
- Burning;
DOSAGE AND ADMINISTRATION
If significant diarrhea occurs during therapy, this antibiotic should be discontinued (see WARNING box).
Adults: Serious infections —150 to 300 mg every 6 hours.
More severe infections —300 to 450 mg every 6 hours.
Pediatric Patients: Serious infections —8 to 16 mg/kg/day (4 to 8 mg/lb/day) divided into three or four equal doses. More severe infections —16 to 20 mg/kg/day (8 to 10 mg/lb/day) divided into three or four equal doses.
To avoid the possibility of esophageal irritation, Clindamycin HCl Capsules should be taken with a full glass of water.
Serious infections due to anaerobic bacteria are usually treated with Clindamycin Phosphate Sterile Solution. However, in clinically appropriate circumstances, the physician may elect to initiate treatment or continue treatment with Clindamycin HCl Capsules.
In cases of ß-hemolytic streptococcal infections, treatment should continue for at least 10 days.
Anda baru saja membaca artikel yang berkategori administration /
Clindamycin /
dosage /
indication /
Side Effects
dengan judul Clindamycin Side Effects Indication and Usage. Anda bisa bookmark halaman ini dengan URL https://medipub.blogspot.com/2011/05/clindamycin-side-effects-indication-and_13.html. Terima kasih!
Ditulis oleh:
Unknown - Friday, 13 May 2011
